| Direct detection of early-stage cancers using circulating tumor DNA J Phallen, M Sausen, V Adleff, A Leal, C Hruban, J White, V Anagnostou, ... Science translational medicine 9 (403), eaan2415, 2017 | 810 | 2017 |
| Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer. cancer discov, 2016 | 674* | 2016 |
| Control of PD-L1 expressioon by oncogenic activation of the AKT/mTOR pathway in non-small cell lung cancer. DPA Lastwika KJ, Wilson W 3rd, Li QK, Norris J, Xu H, Ghazarian SR, Kitagawa ... Cancer Res 76, 227-238, 2016 | 592 | 2016 |
| Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to … L Osmani, F Askin, E Gabrielson, QK Li Seminars in cancer biology 52, 103-109, 2018 | 516 | 2018 |
| Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes CM Heaphy, AP Subhawong, SM Hong, MG Goggins, EA Montgomery, ... The American journal of pathology 179 (4), 1608-1615, 2011 | 481 | 2011 |
| The genomic landscape of response to EGFR blockade in colorectal cancer A Bertotti, E Papp, S Jones, V Adleff, V Anagnostou, B Lupo, M Sausen, ... Nature 526 (7572), 263, 2015 | 410 | 2015 |
| Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway H Miao, BR Wei, DM Peehl, Q Li, T Alexandrou, JR Schelling, JS Rhim, ... Nature cell biology 3 (5), 527-530, 2001 | 409 | 2001 |
| Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients M Sausen, J Phallen, V Adleff, S Jones, RJ Leary, MT Barrett, ... Nature communications 6 (1), 7686, 2015 | 408 | 2015 |
| Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. CPTA Consortium. Cell 179 (4), 964-983, 2019 | 289 | 2019 |
| Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma Cell 182 (1), 200-225, 2020 | 272 | 2020 |
| Protein kinase Cδ is required for p47phox phosphorylation and translocation in activated human monocytes EA Bey, B Xu, A Bhattacharjee, CM Oldfield, X Zhao, Q Li, ... The Journal of Immunology 173 (9), 5730-5738, 2004 | 206 | 2004 |
| Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020 | 202 | 2020 |
| Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor … Y Liu, J Chen, A Sethi, QK Li, L Chen, B Collins, LCJ Gillet, B Wollscheid, ... Molecular & Cellular Proteomics 13 (7), 1753-1768, 2014 | 194 | 2014 |
| Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell, 2021 | 189 | 2021 |
| Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung CancerDynamics of ctDNA and TCR Repertoire during Anti-PD1 V Anagnostou, PM Forde, JR White, N Niknafs, C Hruban, J Naidoo, ... Cancer research 79 (6), 1214-1225, 2019 | 184 | 2019 |
| INSM1 demonstrates superior performance to the individual and combined use of synaptophysin, chromogranin and CD56 for diagnosing neuroendocrine tumors of the thoracic cavity LM Rooper, R Sharma, QK Li, PB Illei, WH Westra The American Journal of Surgical Pathology 41 (11), 1561-1569, 2017 | 128 | 2017 |
| Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ... Cancer cell 39 (3), 361-379. e16, 2021 | 126 | 2021 |
| Overexpression of α (1, 6) fucosyltransferase associated with aggressive prostate cancer X Wang, J Chen, QK Li, SB Peskoe, B Zhang, C Choi, EA Platz, H Zhang Glycobiology 24 (10), 935-944, 2014 | 114 | 2014 |
| Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer V Anagnostou, N Niknafs, K Marrone, DC Bruhm, JR White, J Naidoo, ... Nature Cancer 1 (1), 99-111, 2020 | 112 | 2020 |
| The utility of napsin‐A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas LM Stoll, MW Johnson, E Gabrielson, F Askin, DP Clark, QK Li Cancer cytopathology 118 (6), 441-449, 2010 | 109 | 2010 |
Frederic AskinProfessor of Pathology, Johns Hopkins School of MedicineVerified email at jhmi.edu
